Congress·In Committee·H.R. 8857

Next GEN Act of 2026

Drug Pricing: Delaying Negotiations for Certain New Medicines

22 days ago·View on Congress.gov·Read full text

The Next GEN Act of 2026 is currently in the early stages of the legislative process. It has been sent to the House Committee on Energy and Commerce and the Committee on Ways and Means for review. The bill is actively moving as it waits for these committees to examine its details.

Legislative Progress

House

Senate

President

Law

Could go either way

The bill has support from both parties, which is a good sign for any legislation. However, changes to drug pricing rules are often debated heavily and many bills never make it out of committee.

Key Points

This bill changes how long certain new drugs are protected from government price negotiations. It focuses on a specific type of medicine called engineered cyclic peptides, which are often used in advanced treatments for various diseases.
Currently, the government can start negotiating prices for many new drugs after they have been on the market for 7 years. This bill would push that timeline back to 11 years for these specific medicines, giving companies more time before prices might be lowered.
The goal of the change is to encourage companies to spend more money on research for these complex drugs. Because these medicines are difficult to create and test, supporters argue they need more time to earn back their development costs.
This policy would mainly affect patients who use these specific high-tech drugs and the companies that make them. If passed, it could mean these drugs stay at their original prices for four extra years before Medicare can step in to negotiate lower rates.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

Milestones

2 milestones2 actions

May 15, 2026House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

May 15, 2026

Introduced in House

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

News

No related news coverage found for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Next GEN Act of 2026

Bill NumberHR 8857

Congress119th Congress

ChamberHouse of Representatives

Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.